The authors regret that the age group distributions in Table 2 and Table 3 are inaccurate. The revised, accurate distributions are presented below. The results presented for the overall cohort in-text (Section 3.2) are accurate .
Table 2.
Clinical and demographic comparisons of RSV-positive and RSV-negative children.
| Total (N = 3168) | RSV-positive (N = 1397) | RSV-negative (N = 1771) | p-Value |
|---|---|---|---|
| 0–1 months | 415 (30%) | 579 (33%) | <0.01 |
| 2–5 months | 543 (39%) | 519 (29%) | |
| 6–11 months | 275 (20%) | 353 (20%) | |
| 12–23 months | 164 (12%) | 320 (18%) |
Table 3.
Clinical and demographic comparisons of lower respiratory tract infection by RSV-positive, other virus-positive, and virus-negative children.
| Total (N = 2263) | RSV-positive LRTI (N = 1210) | Virus other-positive LRTI (N = 785) | Virus-negative LRTI (N = 268) | p-Value |
|---|---|---|---|---|
| 0–1 months | 289 (24%) | 87 (11%) | 51 (19%) | <0.01 |
| 2–5 months | 493 (41%) | 246 (31%) | 81 (30%) | |
| 6–11 months | 269 (22%) | 242 (31%) | 70 (26%) | |
| 12–23 months | 159 (13%) | 210 (27%) | 66 (25%) |
The authors would like to apologise for any inconvenience caused.